Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Dec 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst shares the impact of ML applications in LS

Oct 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Google’s DeepMind turns first profit as revenues soar

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Bridging the ESG Valley of Death

Nov 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Bright New Age of Venture Capital

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Dec 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict growth in Pharma-AI use research

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding